Cargando…

Time resolved measure of coronary sinus flow following regadenoson administration

Detalles Bibliográficos
Autores principales:	Booker, O Julian, Bandettini, Patricia, Kellman, Peter, Wilson, Joel, Leung, Steve, Vasu, Sujethra, Shanbhag, Sujata, Henry, Jennifer, Lowrey, Tracy, Mancini, Christine, Arai, Andrew E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106603/ http://dx.doi.org/10.1186/1532-429X-13-S1-O74

Ejemplares similares

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study
por: Bandettini, W Patricia, et al.
Publicado: (2012)

Concordance and diagnostic accuracy of vasodilator stress cardiac MRI and 320-detector row coronary CTA
por: Chen, Marcus Y., et al.
Publicado: (2013)

Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015)

In the absence of obstructive coronary artery disease, patients with class II and III obesity have decreased myocardial perfusion reserve
por: Bandettini, W Patricia, et al.
Publicado: (2014)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Image quality and diagnostic accuracy of inline motion-corrected (moco) first-pass stress myocardial perfusion images
por: Shanbhag, Sujata M, et al.
Publicado: (2011)

Regadenoson blood flow in type 1 diabetes (RABIT(1)D Study)
por: Groves, Daniel W, et al.
Publicado: (2014)

Clinical impact of cardiovascular magnetic resonance in evaluation for possible arrhythmogenic right ventricular dysplasia/cardiomyopathy
por: Choi, Andrew D, et al.
Publicado: (2015)

Heterogeneity of resting and hyperemic myocardial blood flow in healthy volunteers: a quantitative CMR perfusion pixel-map study
por: Greve, Anders M, et al.
Publicado: (2014)

Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study(†)
por: Hammer-Hansen, Sophia, et al.
Publicado: (2016)

Characterization of cardiac masses with T1 mapping
por: Saba, Shahryar G, et al.
Publicado: (2015)

Dobutamine induced changes in aortic stiffness: influence of obesity in middle aged and elderly individuals with hypertension, diabetes or coronary artery disease
por: Vasu, Sujethra, et al.
Publicado: (2013)

Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience
por: Kellman, Peter, et al.
Publicado: (2012)

Evaluation of systemic capillary leak syndrome patients with cardiac magnetic resonance imaging
por: Leung, Steve W, et al.
Publicado: (2012)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

High prevalence of atypical delayed enhancement in alkaptonuria
por: Chen, Marcus Y, et al.
Publicado: (2014)

LV wall motion assessment during regadenoson vasodilator stress CMR
por: Jesinger, Michael, et al.
Publicado: (2016)

Non-contrast quantitative T1-mapping indicates that salvaged myocardium develops edema during coronary occlusion, whereas infarction exhibits evidence of additional reperfusion injury
por: Ugander, Martin, et al.
Publicado: (2011)

Understanding why edema in salvaged myocardium is difficult to detect by late gadolinium enhancement
por: Ugander, Martin, et al.
Publicado: (2012)

Prevalence and prognosis of non-ischemic patterns of late gadolinium enhancement in older adults by cardiovascular MR in the ICELAND-MI study
por: Shanbhag, Sujata M, et al.
Publicado: (2016)

Comparison of arterial input function measured from dual-bolus and dual-sequence dynamic contrast-enhanced cardiac magnetic resonance imaging
por: Hsu, Li-Yueh, et al.
Publicado: (2011)

Nonlinear myocardial perfusion imaging with motion corrected reconstruction: validation via quantitative flow mapping
por: Xue, Hui, et al.
Publicado: (2016)

Regadenoson administration and QT interval prolongation during pharmacological radionuclide myocardial perfusion imaging
por: Rafiq, Arsalan, et al.
Publicado: (2020)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Interobserver reproducibility of fully quantitative pixel-wise analysis of clinical CMR perfusion imaging
por: Conn, Hannah, et al.
Publicado: (2014)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol
por: Thomas, Gregory S., et al.
Publicado: (2017)

Towards reliable myocardial blood-oxygen-level-dependent (BOLD) CMR using late effects of regadenoson with simultaneous (13)n-ammonia pet validation in a whole-body hybrid PET/MR system
por: Yang, Hsin-Jung, et al.
Publicado: (2016)

An Unusual Cause of Acute Abdominal Pain and Unexplained Dyspnea in a Young Man: A Sinus of Valsalva Aneurysm
por: Annabathula, Rahul V., et al.
Publicado: (2022)

Characterization of myocardial T1-mapping bias caused by intramyocardial fat in inversion recovery and saturation recovery techniques
por: Kellman, Peter, et al.
Publicado: (2015)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

A comparison of cine CMR imaging at 0.55 T and 1.5 T
por: Bandettini, W. Patricia, et al.
Publicado: (2020)

Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6gtf3vgngsnggt5q1rpso46n6h